All episodes
MSI-High Rectal Cancer Treatment
NATALEE + a slew of FDA updates
ESMO 2024
Doxorubicin + Trabectedin
Chapter 1. Doses Matter
Cross-Trial Comparison Don'ts
Olanzapine For MEC
Afamitresgene Autoleucel & Vorasidenib
Perioperative ICI Trial Design & Blood Test Screening For Colorectal Cancer
The Auto Transplant Breast Cancer Scandal
Vacation Reflections
June '24 Updates & ATOPP Travelogue
MARIPOSA
ViPOR
Imetelstat, Targeting Telomerase
ASCO 2024
Updated ASCO-ONS Antineoplastic Safety Standards
Tarlatamab
QT Prolongation In Oncology
Pro-MACE-CytaBOM
Tisotumab Vedotin, HD Mtx In CNS Lymphoma & Class III BRAF Mutations
Late April Updates
NSCLC In A Nutshell
HOPA '24, Site Agnositc T-DXd, & ALINA
Tumor Lysis Syndrome
Updates In RCC, Pancreatic Cancer, And Skin Cancer In SOT
Colon Cancer Screening Wars
Bladder Cancer Updates
SPARED & D-TORCH
Lifileucel & FLAURA2 Updates
NAPOLI 3, POUT, & Ivosidenib - Azole DDIs
Small Cell Carcinoma, Prostate Edition
Rethinking Some Fundamental Considerations
Jan 2024 Updates...
Development Of Generic Lenalidomide with Dr. Ryan Beechinor
Lenalidomide
2023 New Drug Review
ASH23 Appetizers
VISTA
Gamma Secretase Inhibition et al
Repotrectinib & Capivasertib
Fruquintinib And Osimertinib-Chemo in Combo?
Elderly AML & Burkitt Lymphoma Updates
Landmarks Of Stage III NSCLC
ESMO 2023
Enzalutamide monotherapy? Plus, nivolumab & pembrolizumab approval updates
BRAF V600E Updates
Press Release Updates
Imatinib [Re-release]
Carboplatin Paclitaxel in Ovarian Cancer
HER3-DXd & Motixafortide
RECISTance Is Futile
DPYD Variant Dosing & ICIs In Pancreatic Cancer
Nab-Paclitaxel
Niraparib + Abiraterone, Elranatamab, & Melphalan Updates
Talquetamab & STOP-CA
Ruby Trial & Quizartinib Toxicity
BCOP Study Tips
Chemotherapy Sequencing In Colorectal Cancer
Phase 1 Clinical Trials In Oncology with Dr. Donald Harvey
Investigational Drug Services In Oncology with Dr. Jackie Saunders
NADIM II & Favorable Risk RCC
Glofitamab & TALAPRO - 2
ASCO '23 Entrees
ASCO '23 Appetizers
PROpel and Cilostazol to Prevent Paclitaxel Neuropathy
Epcoritamab
Trimodality Treatment For Bladder Cancer
GAIA-CLL13 & COSMIC-313
SUNLIGHT
QuANTUM First (Quizartinib 1st Line in AML)
ICI + Bacterial Supplementation
Neoadjuvant Chemo In Breast Cancer
Olanzapine & Pembrolizumab (endometrial, urothelial) Updates
[Re-release] Tales of Brave Iressa (2017)
Linezolid vs. Vanc In Neutropenic Fever
Chemo-Induced Ovarian Dysfunction
S1801 (Neoadjuvant Pembro In Melanoma)
DA-EPOCH (R)
Cannabis Use With ICIs
Instant KarMMa
CodeBreak200 And Elderly AML Survival
Adjuvant Pembrolizumab (NSCLC), Elacestrant, & Pirtobrutinib
HER2 Targeting Era Of Colorectal Cancer Begins
Adjuvant Interferon In Melanoma
Breast Cancer In A Nutshell
Mosunetuzumab And Same-day Pegfilgrastim w/ ddAC
2022 New Drug Review
Project Renewal: Capecitabine
ASH 2022 Highlights
TILs, Olutasidenib, T-DXd
Bad News For Belantamab-Mafodotin And Atezolizumab's Bladder Cancer Indication
Mirvetuximab Soravtansine
Metastatic NSCLC Updates: Role of CTLA-4 inhibitors?
No Room for MABs at the INN
Tremelimumab & Teclistamab
Pemetrexed Maintenance
Allo CAR-T & Aprepitant For EGFR TKI Pruritis
Futibatinib, ESR1, & GPRC5D
Thiosulfate And Selpercatinib